Nexalin Technology (NXL) Other financing activities (2021)
Nexalin Technology (NXL) posted quarterly Other financing activities of -$1.0 for Q4 2021.
Nexalin Technology (NXL) Other financing activities (2021) Analysis & Trends
Nexalin Technology's Other financing activities history runs 1 years deep, the most recent figure standing at -$1.0 for Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.08 Mn | 6.07 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.00 |
| Dec 31, 2021 | -1.00 |